Ross D. Margulies, JD, MPH
San Diego—A proposed rule published by the Department of Health and Human Services Office of Inspector General (OIG) earlier this year that would eliminate discount safe harbor protection for drug manufacturer rebates offered to Medicare Part D and Medicaid managed care plans has plenty in the pharmacy industry up in arms. Some 25,000 comments poured in to the OIG through early April from multiple stakeholders, including pharmacy benefit managers